Search alternatives:
significant treatment » significant agreement (Expand Search), significant enrichment (Expand Search), significant threat (Expand Search)
treatment decreased » treatment increases (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
significant treatment » significant agreement (Expand Search), significant enrichment (Expand Search), significant threat (Expand Search)
treatment decreased » treatment increases (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
-
141
-
142
-
143
-
144
-
145
The table shows the significant and non-significant altered group with different parameters.
Published 2025Subjects: -
146
Evogliptin attenuates the phenotypic switch of VSMCs during CER treatment by decreasing the osteogenesis-associated genes <i>in-vitro.</i>
Published 2025“…(B, C) Summarized bar graph showed EVO significantly decreased calcium deposition and calcium content in CER treated P<sub>i</sub>-induced VSMCs. …”
-
147
Mast cell density and tactile sensitivity decreased after 10 preventative imatinib treatments followed by repeated MI challenges.
Published 2020“…Results displayed as mean ± SEM; n = 6/treatment group. Significance with respect to control group, * p<0.05. …”
-
148
-
149
-
150
-
151
-
152
-
153
-
154
-
155
-
156
-
157
-
158
Annual number of outpatient visits in recurrence and non-recurrence groups.
Published 2025Subjects: -
159
-
160